abstract |
A stabilized 13,14-dihydro-15-ketoprostaglandin composition comprising an intimate mixture ofn a) a therapeutically effective amount of at least one compound selected from 13,14-dihydro-15-ketoprostaglandins and b) at least one compound selected from pharmaceutically acceptable etherized cyclodextrins. |